NRIX — NURIX THERAPEUTICS INC

Ownership history in Engineers Gate Manager LP  ·  6 quarters on record

This page tracks every 13F SEC filing in which Engineers Gate Manager LP reported a position in NURIX THERAPEUTICS INC (NRIX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2024 Q2)
Avg. % of fund
0.01%
First filed
2023 Q4
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 18,492 -15,784 -46.0% 0.00% $171K $9.24
2025 Q2 REDUCED 34,276 -18,284 -34.8% 0.00% $390K $11.39
2025 Q1 ADDED 52,560 +27,585 +110.5% 0.01% $624K $11.88
2024 Q3 ADDED 24,975 +423 +1.7% 0.01% $561K $22.47
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    NRIX price (monthly, adj. close)

Other funds also holding NRIX

As of 2025 Q4 — sorted by position size

Redmile Group, LLC 3Y 7Y 11.31% GENERAL ATLANTIC, L.P. 3Y 7Y 3.23% Vestal Point Capital, LP 3.02% Commodore Capital LP 3Y 2.87% Elmind Capital, LP 2.58% Kynam Capital Management, LP 3Y 2.39% Deep Track Capital, LP 3Y 2.38% Longaeva Partners L.P. 1.48% BRAIDWELL LP 3Y 1.32% PERCEPTIVE ADVISORS LLC 3Y 7Y 1.2%
← Back to Engineers Gate Manager LP Holdings